摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(±)-(15S*,16R*)-16-hydroxy-16,22-dihydroapparicine

中文名称
——
中文别名
——
英文名称
(±)-(15S*,16R*)-16-hydroxy-16,22-dihydroapparicine
英文别名
(15RS,16SR)-16-hydroxy-16,22-dihydroapparicine;(12R,13S,14E)-14-ethylidene-12-methyl-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraen-12-ol
(±)-(15S*,16R*)-16-hydroxy-16,22-dihydroapparicine化学式
CAS
——
化学式
C18H22N2O
mdl
——
分子量
282.385
InChiKey
PZYMRTAVKVZYMI-HXVIRUTNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    21
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    39.3
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    2-碘-1H-吲哚正丁基锂四丁基氟化铵 、 sodium hydride 、 二异丁基氢化铝potassium carbonate乙二胺三苯基膦 、 potassium hydroxide 作用下, 以 四氢呋喃正己烷二氯甲烷甲苯 为溶剂, 反应 82.33h, 生成 (±)-(15S*,16R*)-16-hydroxy-16,22-dihydroapparicine
    参考文献:
    名称:
    (+)‐ 16‐羟基‐16,22-二氢app啶胺的结构测定和全合成
    摘要:
    在这里,我们描述了第一个不对称的总合成,以及天然存在的16-羟基-16,22-二氢app啶胺的相对和绝对立体化学的确定。关键步骤包括:1)一种新的膦亚胺介导的级联反应,以构建独特的1-氮杂双环[4.2.2]癸烷核心,包括假氨基类型部分;2)通过Felkin-Anh过渡态具有高立体定向性的1,2-丙烯腈或甲基酮的1,2-加成反应,以构建四取代的碳中心;3)酮酯的分子内手性转移迈克尔反应,具有邻近基团的参与,在目标分子的C15处引入手性中心。此外,我们评估了合成(+)‐(15 S,16 R)‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐é细细ane板衬膜及其中间体,可以抵抗耐氯喹的恶性疟原虫(K1株)寄生虫。
    DOI:
    10.1002/chem.201300292
点击查看最新优质反应信息

文献信息

  • The first total synthesis and reassignment of the relative stereochemistry of 16-hydroxy-16,22-dihydroapparicine
    作者:Yoshihiko Noguchi、Tomoyasu Hirose、Yujiro Furuya、Aki Ishiyama、Kazuhiko Otoguro、Satoshi Ōmura、Toshiaki Sunazuka
    DOI:10.1016/j.tetlet.2012.01.110
    日期:2012.4
    We report the first total synthesis and reassignment of the relative stereochemistry of naturally occurring 16-hydroxy-16,22-dihydroapparicine. Our novel route proceeds by a cascade reaction to efficiently construct a 1-azabicyclo[4.2.2]decane core, along with two stereocenters (C-15 and C-16). The C-16 quaternary carbon was constructed through stereospecific 1,2-addition using an indole nucleophile
    我们报告了自然界中的16-羟基-16,22-dihydroapparicine的相对立体化学的第一次总合成和重新分配。我们的新途径是通过级联反应进行的,以有效地构建1-azabicyclo [4.2.2]癸烷核心,以及两个立体中心(C-15和C-16)。C-16季碳是通过使用吲哚亲核试剂与醛或甲基酮进行立体有规的1,2-加成而构建的。目标产物的两种非对映异构体的立体定向合成揭示了天然化合物的真正相对立体化学
查看更多

同类化合物

白坚木辛碱 瓦来萨明碱N-氧化物 19,20-(E)-瓦来萨明碱 (4E,5R)-4-亚乙基-1,3,4,5,6,7-六氢-6-亚甲基-2,5-乙桥-2H-氮杂环辛烷并[4,3-b]吲哚 Brafouedine Gomezine Isobrafouedine 16S-Hydroxy-16,22-dihydro-(-)-apparicine Gomezine hydrochloride (12R,13S,14Z)-14-ethylidene-12-methyl-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraen-12-ol (±)-(15S*,16R*)-16-hydroxy-16,22-dihydroapparicine Tabernoschizine (13S,14Z)-14-ethylidene-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene 16(S)-Hydroxy-16,22-dihydroapparicine 2,5-Ethano-2H-azocino[4,3-b]indole-6-carboxylic acid, 4-ethylidene-1,3,4,5,6,7-hexahydro-6-(hydroxymethyl)-, methyl ester 2,5-Ethano-2H-azocino[4,3-b]indole-6-carboxylic acid, 6-[(acetyloxy)methyl]-4-ethylidene-1,3,4,5,6,7-hexahydro-, methyl ester (14E)-14-ethylidene-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene;hydron;chloride methyl (12R,13S,14E)-14-ethylidene-12-methoxy-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene-12-carboxylate methyl (13S,14E)-14-ethylidene-12-(hydroxymethyl)-1-oxido-10-aza-1-azoniatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene-12-carboxylate methyl (12S,13S)-14-ethylidene-12-(hydroxymethyl)-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene-12-carboxylate (13S)-14-ethylidene-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene (+/-)-apparicine 14-Ethylidene-6-methoxy-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4(9),5,7-tetraene 14-Oxa-1,10-diazapentacyclo[15.3.1.03,11.04,9.012,18]henicosa-3(11),4,6,8,16-pentaene-12-carboxylic acid Methyl 15-ethenyl-14-oxa-1,10-diazapentacyclo[13.3.1.03,11.04,9.012,16]nonadeca-3(11),4,6,8-tetraene-12-carboxylate 14-Ethylidene-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4(9),5,7-tetraen-6-ol Methyl 15-ethenyl-16-hydroxy-14-oxa-1,10-diazapentacyclo[13.3.1.03,11.04,9.012,16]nonadeca-3(11),4,6,8-tetraene-12-carboxylate 14-Ethylidene-12-methyl-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraen-12-ol Apparicin Methyl 14-ethylidene-12-(hydroxymethyl)-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene-12-carboxylate [14-Ethylidene-12-(2-hydroxyacetyl)-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraen-12-yl]methyl acetate angustilobine B, (rac)- 12,14-Dimethyl-13-oxa-1,10-diazapentacyclo[13.3.1.03,11.04,9.012,16]nonadeca-3(11),4,6,8-tetraen-15-ol 14-Ethylidene-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraen-13-ol 1-[14-Ethylidene-12-(hydroxymethyl)-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraen-12-yl]-2-hydroxyethanone 14-Ethylidene-6-methoxy-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4(9),5,7-tetraen-13-ol 3'-Methyl-12-methylidenespiro[1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene-14,2'-oxirane] Methyl 12-(acetyloxymethyl)-14-ethylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene-12-carboxylate